MCL, CLL, FL, and DLBCL samples all showed significant increases in cytochrome c release when using both venetoclax and MS1 together in the BH3 profiling assay, compared to single agents venetoclax or MS1 (all p < 0.05, Figure 4A,C,D). This evidence concerns the gene CYCS and B-cell chronic lymphocytic leukemia.